Transfection Reagents and Equipment Market by Method (Biochemical (Calcium Phosphate, Lipofection, Dendrimers), Physical (Electroporation, Nucleofection), Viral)), Application (Biomedical, Protein Production), End User - Global Forecast to 2021

トランスフェクション試薬&装置の世界市場予測(~2021):方法別、用途別(生物医学、蛋白質製造)、需要先別

◆タイトル:Transfection Reagents and Equipment Market by Method (Biochemical (Calcium Phosphate, Lipofection, Dendrimers), Physical (Electroporation, Nucleofection), Viral)), Application (Biomedical, Protein Production), End User - Global Forecast to 2021
◆商品コード:MAM-BT-3562
◆調査・発行会社:MarketsandMarkets
◆発行日:2017年1月13日
◆ページ数:212
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:バイオ
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥627,150見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥738,150見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥904,650見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、トランスフェクション試薬&装置の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、方法別分析、用途別分析、需要先別分析、地域別分析、トランスフェクション試薬&装置の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The global transfection reagents and equipment market is expected to reach USD 1.02 billion by 2021 from USD 715.4 million in 2016, at a CAGR of 7.5% during the forecast period 2016 to 2021.
Over the years, the transfection reagents and equipment market has witnessed various technological advancements in equipment as well as reagents to address the requirements of researchers and biotechnology & biopharmaceutical companies. These advancements have led to the development of transfection instruments that are of higher efficiency. It has also resulted in efficient quantitative and qualitative transfection in a wide range of cells, including the hard-to-transfect cells.
In 2016, the reagents segment is expected to account for the largest share of the market, by product. The biochemical method segment is expected to account for the largest share of the market, by method. The academic & research institutes segment is expected to account for the largest share of the market, by end user. The biomedical research segment is expected to account for the largest share of the market, by application.

In 2016, North America is expected to account for the largest share of the global transfection reagents and equipment market, followed by Europe, Asia-Pacific, and RoW. The Asia-Pacific region is expected to grow at the highest CAGR during the forecast period, with emphasis on India, China, and Japan. Growth in these countries can be attributed to the increase in research activities conducted in these regions, rapid expansion of the biotechnology and pharmaceutical industry, government as well as private sector support, increase in cancer incidence, and favorable regulatory framework.

The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopted various strategies such as agreements, collaborations and partnerships, new product launches, expansions, and acquisitions to increase their presence and establish a strong foothold in the global market.

In-depth interviews were conducted with CEOs, sales and marketing directors, other innovation and technology directors, and executives from various key organizations operating in the transfection reagents and equipment market
 By Company Type: Tier 1: 56%, Tier 2: 34%, and Tier 3: 10%
 By Designation: Director Level: 28%, C-level: 19%, and Others: 53%
 By Region: North America: 27%, Europe: 27%, APAC: 30%, and RoW: 16%

The prominent players in the global transfection reagents and equipment market include Thermo Fisher Scientific, Inc. (U.S.), Promega Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), and QIAGEN N.V. (Netherlands). These companies held a dominant position in the market mainly due to their well-established presence in the field of genomics, presence in over 50 countries, high R&D investments, and strong sales and distribution force. Other players in the market include Polyplus-transfection SA (France), Bio-Rad Laboratories (U.S.), Lonza Group (Switzerland), Sigma-Aldrich Corporation (U.S.), Mirus Bio LLC (U.S.), and MaxCyte Inc. (U.S.).

Research Coverage
The report provides a picture of the transfection reagents and equipment market across different industry verticals and regions. It aims at estimating the market size and future growth potential of this market across different segments such as by product, method, end user, application, and regions. Furthermore, the report also includes an in-depth competitive analysis of the key players in the market along with their company profiles, recent developments, product pipeline, and key market strategies.

Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms, to garner a greater market share. Firms purchasing the report could use any one or combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on product portfolios offered by the top players in the transfection reagents and equipment market. The report analyzes the transfection reagents and equipment market, by product, method, end user, application, and region
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the transfection reagents and equipment market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various transfection methods across regions
• Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the transfection technologies market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the transfection reagents and equipment market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 19
1.1 OBJECTIVES OF THE STUDY 19
1.2 MARKET DEFINITION 19
1.3 MARKET SCOPE 20
1.3.1 MARKETS COVERED 20
1.3.2 YEARS CONSIDERED FOR THE STUDY 20
1.4 CURRENCY 21
1.5 LIMITATIONS 21
1.6 STAKEHOLDERS 21

2 RESEARCH METHODOLOGY 22
2.1 RESEARCH METHODOLOGY STEPS 22
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 23
2.2.1 SECONDARY RESEARCH 23
2.2.1.1 Key data from secondary sources 23
2.2.2 PRIMARY RESEARCH 25
2.2.2.1 Key data from primary sources 26
2.2.2.2 Key insights from primary sources 26
2.2.2.3 Key industry insights 27
2.3 MARKET SIZE ESTIMATION METHODOLOGY 27
2.3.1 MARKET FORECAST METHODOLOGY 29
2.4 MARKET DATA VALIDATION AND TRIANGULATION 30
2.5 ASSUMPTIONS 31

3 EXECUTIVE SUMMARY 32
3.1 INTRODUCTION 32
3.2 CONCLUSION 36

4 PREMIUM INSIGHTS 37
4.1 GLOBAL TRANSFECTION TECHNOLOGIES MARKET 37
4.2 TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION & REGION 38
4.3 GEOGRAPHIC SNAPSHOT: TRANSFECTION TECHNOLOGIES MARKET 39
4.4 TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT (2016 VS. 2021) 40
4.5 TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2016 VS. 2021 (USD MILLION) 40

5 MARKET OVERVIEW 41
5.1 INTRODUCTION 42
5.2 MARKET DYNAMICS 42
5.2.1 DRIVERS 43
5.2.1.1 Technological advancements in transfection technology 43
5.2.1.1.1 CRISPR-Cas9 43
5.2.1.1.2 CAR-T 43
5.2.1.1.3 Three Dimension (3D) transfection technology 44
5.2.1.2 Global alliances among leading research institutes to trigger drug discovery 44
5.2.1.3 Increase in R&D spending and research activities by pharmaceutical and biotech companies 45
5.2.1.4 Growing research activities in cell science 46
5.2.1.5 Increase in demand for synthetic genes 47
5.2.1.6 Rising incidence of cancer worldwide 47
5.2.2 RESTRAINTS 47
5.2.2.1 Selective effectiveness of transfection reagents 47
5.2.2.2 Home brew reagents restrict sale of commercial kits 47
5.2.2.3 High cost of transfection reagents 48
5.2.3 OPPORTUNITIES 48
5.2.3.1 Large-scale transfections 48
5.2.3.2 High-growth opportunities in asian market 48
5.2.3.2.1 India 49
5.2.3.2.2 China 49
5.2.4 CHALLENGES 50
5.2.4.1 Transfection in hard-to-transfect cells 50
5.2.4.2 Cytotoxicity in transfection – a major concern 50

6 TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT 51
6.1 INTRODUCTION 52
6.2 REAGENTS 53
6.3 EQUIPMENT 55

7 TRANSFECTION TECHNOLOGIES MARKET, BY METHOD 56
7.1 INTRODUCTION 57
7.2 BIOCHEMICAL METHODS 58
7.2.1 LIPOFECTION 60
7.2.1.1 Advantages 60
7.2.1.2 Disadvantages 60
7.2.2 CALCIUM PHOSPHATE 61
7.2.2.1 Advantages 61
7.2.2.2 Disadvantages 62
7.2.3 DEAE-DEXTRAN 62
7.2.3.1 Advantages 62
7.2.3.2 Disadvantages 63
7.2.4 DENDRIMERS 63
7.2.4.1 Advantages 63
7.2.4.2 Disadvantages 64
7.3 PHYSICAL 64
7.3.1 ELECTROPORATION 66
7.3.1.1 Advantages 66
7.3.1.2 Disadvantages 66
7.3.2 NUCLEOFECTION 67
7.3.2.1 Advantages 67
7.3.2.2 Disadvantages 67
7.3.3 OTHER METHODS 68
7.3.3.1 Sonoporation 68
7.3.3.2 Genegun 68
7.3.3.2.1 Advantages 68
7.3.3.2.2 Disadvantages 68
7.3.3.3 Magnetofection 69
7.3.3.3.1 Advantages 69
7.3.3.3.2 Disadvantages 69
7.3.3.4 Optoinjection 69
7.3.3.4.1 Advantages 69
7.3.3.4.2 Disadvantages 69
7.4 VIRAL METHODS 70
7.4.1 ADENOVIRUSES 71
7.4.2 RETROVIRUSES 71
7.4.3 ADENOASSOCIATED VIRUSES (AAV) 71

8 TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION 73
8.1 INTRODUCTION 74
8.2 BIOMEDICAL RESEARCH 75
8.2.1 GENE EXPRESSION STUDIES 77
8.2.2 CANCER RESEARCH 78
8.2.3 TRANSGENIC MODELS 79
8.3 PROTEIN PRODUCTION 80
8.4 THERAPEUTIC DELIVERY 81

9 TRANSFECTION TECHNOLOGIES MARKET, BY END USER 83
9.1 INTRODUCTION 84
9.2 ACADEMICS & RESEARCH INSTITUTES 85
9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 86

10 TRANSFECTION TECHNOLOGIES MARKET, BY REGION 88
10.1 INTRODUCTION 89
10.2 NORTH AMERICA 90
10.2.1 U.S. 96
10.2.1.1 Increase in bio-based drug research 96
10.2.1.2 Growing demand for protein-based therapeutics triggers the growth of U.S. market 96
10.2.1.3 Increasing funding for biotechnology and for development of protein-based biologics 97
10.2.1.4 Conferences/meetings/symposiums/workshops 97
10.2.2 CANADA 102
10.2.2.1 Government support for development of protein drugs is expected to drive the market for transfection technologies 102
10.2.2.2 Increasing investments by the canadian government on regenerative medicine to drive market growth 102
10.2.2.3 Increasing funding for genome engineering in Canada likely to boost transfection technologies market 103
10.3 EUROPE 107
10.3.1 GERMANY 113
10.3.1.1 Growing biotech industry and research funding in germany 113
10.3.1.2 Collaboration among bio-pharmaceutical and biotechnology companies for the development of new vaccines is likely to drive the market growth 113
10.3.1.3 Conferences and meetings/workshops in Germany 114
10.3.1.4 Availability of funding for life science research in Germany 114
10.3.2 U.K. 118
10.3.2.1 10,000 genome project initiative in U.K. 118
10.3.2.2 Initiative to increase R&D investments in U.K. 119
10.3.3 REST OF EUROPE 123
10.3.3.1 Growing biotechnology and pharma industry in Italy 123
10.3.3.2 Focus on research in Spain 123
10.3.3.3 Investments and funding for life sciences to drive the transfection technologies market 123
10.3.3.4 Growing research investments in Sweden & Denmark 124
10.4 ASIA-PACIFIC 129
10.4.1 JAPAN 135
10.4.1.1 Rise in biomedical research in Japan 135
10.4.2 CHINA 139
10.4.2.1 Chinese government initiatives for life sciences R&D likely to boost the market 139
10.4.2.2 Industry initiative to boost transfection technology market in China 140
10.4.3 INDIA 144
10.4.3.1 Booming pharmaceutical and biotechnology industries 144
10.4.3.2 Development of bio-clusters in India 144
10.4.4 REST OF ASIA-PACIFIC 149
10.4.4.1 Federal collaborations in Australia 149
10.4.4.2 Funding for research on proteomics and genomics in Australia 149
10.4.4.3 Rising pharmaceutical and biotechnology R&D activities in South Korea 150
10.4.4.4 Government support for strong academic and commercial R&D activities in Taiwan 150
10.4.4.5 Genome Asia 100k initative 151
10.5 REST OF THE WORD (ROW) 155
10.5.1 LATIN AMERICA 155
10.5.1.1 Increasing investment in Brazil and Mexico 155
10.5.1.2 Brazil: investment in research and innovation centers and conferences & workshops 156
10.5.2 MIDDLE EAST & AFRICA 156
10.5.2.1 Increasing focus of major pharmaceutical, biopharmaceutical, and biotechnology firms in Saudi Arabia and the United Arab Emirates (UAE) and African regions 156
10.5.2.2 Genetic testing and genomic analysis in the Middle East 157

11 COMPETITIVE LANDSCAPE 161
11.1 OVERVIEW 161
11.2 MARKET SHARE ANALYSIS 162
11.2.1 INTRODUCTION 162
11.2.2 THERMO FISHER SCIENTIFIC INC. 163
11.2.3 PROMEGA CORPORATION 164
11.2.4 F. HOFFMANN-LA ROCHE LTD 164
11.2.5 QIAGEN N.V. 164
11.3 COMPETITIVE SITUATION AND TRENDS 165
11.4 AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS 166
11.5 NEW PRODUCT LAUNCHES 168
11.6 EXPANSIONS 169
11.7 ACQUISITIONS 170
11.8 OTHER STRATEGIES 171

12 COMPANY PROFILES 172
(Overview, Products and Services, Financials, Strategy & Development)*
12.1 THERMO FISHER SCIENTIFIC INC. (LIFE TECHNOLOGIES) 172
12.2 PROMEGA CORPORATION 175
12.3 QIAGEN N.V. 177
12.4 F. HOFFMANN-LA ROCHE LTD 180
12.5 BIO–RAD LABORATORIES, INC. 182
12.6 MAXCYTE, INC. 184
12.7 LONZA GROUP LTD. 186
12.8 MERCK KGAA 189
12.9 POLYPLUS-TRANSFECTION SA (SUBSIDARY OF ARCHIMED) 193
12.10 MIRUS BIO LLC. 195
*Details on Overview, Products and Services, Financials, Strategy & Development might not be Captured in case of Unlisted Companies.

13 APPENDIX 198
13.1 DISCUSSION GUIDE 198
13.2 OTHER DEVELOPMENTS 203
13.2.1 MAXCYTE INC. 203
13.2.2 LONZA GROUP LTD. 203
13.2.3 QIAGEN N.V. 203
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 204
13.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 206
13.5 AVAILABLE CUSTOMIZATIONS 207
13.6 RELATED REPORTS 208
13.7 AUTHOR DETAILS 209

LIST OF TABLES

TABLE 1 INDICATIVE LIST OF CELL-BASED RESEARCH STUDIES 46
TABLE 2 TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 53
TABLE 3 TRANSFECTION REAGENTS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 54
TABLE 4 TRANSFECTION INSTRUMENTS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 55
TABLE 5 TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD,
2014–2021 (USD MILLION) 58
TABLE 6 BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 59
TABLE 7 BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 59
TABLE 8 LIPOFECTION TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 61
TABLE 9 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR CALCIUM PHOSPHATE METHOD, BY REGION, 2014–2021 (USD MILLION) 62
TABLE 10 DEAE-DEXTRAN TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 63
TABLE 11 DENDRIMER TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 64
TABLE 12 PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 65
TABLE 13 PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 65
TABLE 14 ELECTROPORATION TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 66
TABLE 15 NUCLEOFECTION TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 67
TABLE 16 OTHER PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 70
TABLE 17 VIRAL SYSTEMS 71
TABLE 18 VIRAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 72
TABLE 19 TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 75
TABLE 20 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH,
BY TYPE, 2014-2021 (USD MILLION) 76
TABLE 21 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH,
BY REGION, 2014-2021 (USD MILLION) 76
TABLE 22 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR GENE EXPRESSION STUDIES, BY REGION, 2014-2021 (USD MILLION) 77
TABLE 23 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR CANCER RESEARCH,
BY REGION, 2014-2021 (USD MILLION) 78
TABLE 24 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR TRANSGENIC MODELS,
BY REGION, 2014-2021 (USD MILLION) 79
TABLE 25 INDICATIVE LIST OF FEW RECOMBINANT PROTEINS, VACCINES FROM DIFFERENT CELL TYPES 80
TABLE 26 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PROTEIN PRODUCTION,
BY REGION, 2014-2021 (USD MILLION) 80
TABLE 27 INDICATIVE LIST OF DRUG DELIVERY SYSTEMS FOR VARIOUS DISEASE CONDITIONS 81
TABLE 28 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR THERAPEUTIC DELIVERY,
BY REGION, 2014-2021 (USD MILLION) 82
TABLE 29 TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 85
TABLE 30 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR ACADEMICS & RESEARCH INSTITUTES, BY REGION, 2014–2021 (USD MILLION) 86
TABLE 31 TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2014–2021 (USD MILLION) 87
TABLE 32 TRANSFECTION TECHNOLOGIES MARKET SIZE, BY REGION,
2014-2021 (USD MILLION) 90
TABLE 33 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY, 2014–2021 (USD MILLION) 92
TABLE 34 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION) 92
TABLE 35 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014-2021 (USD MILLION) 93
TABLE 36 NORTH AMERICA: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE,
BY TYPE, 2014-2021 (USD MILLION) 93
TABLE 37 NORTH AMERICA: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE,
BY TYPE, 2014-2021 (USD MILLION) 94
TABLE 38 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 94
TABLE 39 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION) 95
TABLE 40 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014-2021 (USD MILLION) 95
TABLE 41 LIST OF MONOCLONAL ANTIBODIES APPROVED BY FDA IN 2015 97
TABLE 42 INDICATIVE LIST OF UPCOMING EVENTS IN THE U.S. 98
TABLE 43 U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2014-2021 (USD MILLION) 98
TABLE 44 U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD,
2014-2021 (USD MILLION) 99
TABLE 45 U.S.: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE,
2014-2021 (USD MILLION) 99
TABLE 46 U.S.: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE,
2014-2021 (USD MILLION) 100
TABLE 47 U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION,
2014-2021 (USD MILLION) 100
TABLE 48 U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION) 101
TABLE 49 U.S.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER,
2014-2021 (USD MILLION) 101
TABLE 50 CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2014-2021 (USD MILLION) 104
TABLE 51 CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD,
2014-2021 (USD MILLION) 104
TABLE 52 CANADA: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION) 105
TABLE 53 CANADA: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE,
2014-2021 (USD MILLION) 105
TABLE 54 CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION,
2014-2021 (USD MILLION) 106
TABLE 55 CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION) 106
TABLE 56 CANADA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER,
2014-2021 (USD MILLION) 107
TABLE 57 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 109
TABLE 58 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 109
TABLE 59 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD,
2014–2021 (USD MILLION) 110
TABLE 60 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2014–2021 (USD MILLION) 110
TABLE 61 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2014–2021 (USD MILLION) 111
TABLE 62 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 111
TABLE 63 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014–2021 (USD MILLION) 112
TABLE 64 EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 112
TABLE 65 INDICATIVE LIST OF UPCOMING EVENTS IN GERMANY 114
TABLE 66 GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 115
TABLE 67 GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD,
2014–2021 (USD MILLION) 115
TABLE 68 GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2014–2021 (USD MILLION) 116
TABLE 69 GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2014–2021 (USD MILLION) 116
TABLE 70 GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 117
TABLE 71 GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014–2021 (USD MILLION) 117
TABLE 72 GERMANY: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 118
TABLE 73 U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 119
TABLE 74 U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD,
2014–2021 (USD MILLION) 120
TABLE 75 U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE BIOCHEMICAL METHOD,
BY TYPE 2014–2021 (USD MILLION) 120
TABLE 76 U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE PHYSICAL METHOD, BY TYPE 2014–2021 (USD MILLION) 121
TABLE 77 U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 121
TABLE 78 U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014–2021 (USD MILLION) 122
TABLE 79 U.K.: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 122
TABLE 80 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT, 2014–2021 (USD MILLION) 125
TABLE 81 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD, 2014–2021 (USD MILLION) 125
TABLE 82 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2014–2021 (USD MILLION) 126
TABLE 83 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD, BY TYPE, 2014–2021 (USD MILLION) 126
TABLE 84 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 127
TABLE 85 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014–2021 (USD MILLION) 127
TABLE 86 REST OF EUROPE: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 128
TABLE 87 ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY COUNTRY,
2014–2021 (USD MILLION) 131
TABLE 88 ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 131
TABLE 89 ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD,
2014–2021 (USD MILLION) 132
TABLE 90 ASIA-PACIFIC: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE,
BY TYPE, 2014–2021 (USD MILLION) 132
TABLE 91 ASIA-PACIFIC: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 133
TABLE 92 ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION, 2014–2021 (USD MILLION) 133
TABLE 93 ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014–2021 (USD MILLION) 134
TABLE 94 ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER, 2014–2021 (USD MILLION) 134
TABLE 95 JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 136
TABLE 96 JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD,
2014–2021 (USD MILLION) 136
TABLE 97 JAPAN: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 137
TABLE 98 JAPAN: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 137
TABLE 99 JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 138
TABLE 100 JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014–2021 (USD MILLION) 138
TABLE 101 JAPAN: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 139
TABLE 102 CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 140
TABLE 103 CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD,
2014–2021 (USD MILLION) 141
TABLE 104 CHINA: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 141
TABLE 105 CHINA: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 142
TABLE 106 CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 142
TABLE 107 CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014–2021 (USD MILLION) 143
TABLE 108 CHINA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 143
TABLE 109 INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 145
TABLE 110 INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD,
2014–2021 (USD MILLION) 146
TABLE 111 INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2014–2021 (USD MILLION) 146
TABLE 112 INDIA: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE,
2014–2021 (USD MILLION) 147
TABLE 113 INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION,
2014–2021 (USD MILLION) 147
TABLE 114 INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014–2021 (USD MILLION) 148
TABLE 115 INDIA: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER,
2014–2021 (USD MILLION) 148
TABLE 116 REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE,
BY PRODUCT, 2014–2021 (USD MILLION) 151
TABLE 117 REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE,
BY METHOD, 2014–2021 (USD MILLION) 151
TABLE 118 REST OF ASIA-PACIFIC: BIOCHEMICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 152
TABLE 119 REST OF ASIA-PACIFIC: PHYSICAL TRANSFECTION TECHNOLOGIES MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 152
TABLE 120 REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE,
BY APPLICATION, 2014–2021 (USD MILLION) 153
TABLE 121 REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014–2021 (USD MILLION) 153
TABLE 122 REST OF ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SIZE,
BY END USER, 2014–2021 (USD MILLION) 154
TABLE 123 ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2014–2021 (USD MILLION) 157
TABLE 124 ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY METHOD,
2014–2021 (USD MILLION) 158
TABLE 125 ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOCHEMICAL METHOD, BY TYPE, 2014–2021 (USD MILLION) 158
TABLE 126 ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR PHYSICAL METHOD,
BY TYPE, 2014–2021 (USD MILLION) 159
TABLE 127 ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY APPLICATION,
2014-2021 (USD MILLION) 159
TABLE 128 ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE FOR BIOMEDICAL RESEARCH, BY TYPE, 2014-2021 (USD MILLION) 160
TABLE 129 ROW: TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER,
2014-2021 (USD MILLION) 160
TABLE 130 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS 2013–2016 167
TABLE 131 NEW PRODUCT LAUNCHES, 2013-2016 168
TABLE 132 EXPANSIONS, 2013–2016 169
TABLE 133 ACQUISITIONS, 2013–2016 170
TABLE 134 OTHER STRATEGIES, 2013–2016 171


LIST OF FIGURES

FIGURE 1 RESEARCH METHODOLOGY: GLOBAL TRANSFECTION TECHNOLOGIES MARKET 22
FIGURE 2 BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 25
FIGURE 3 SAMPLING FRAME: PRIMARY RESEARCH 25
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 28
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 28
FIGURE 6 RESEARCH DESIGN: GLOBAL TRANSFECTION TECHNOLOGIES MARKET 29
FIGURE 7 DATA TRIANGULATION METHODOLOGY 30
FIGURE 8 TRANSFECTION TECHNOLOGIES MARKET, BY METHOD (2016) 32
FIGURE 9 TRANSFECTION TECHNOLOGIES MARKET, BY PRODUCT (2016–2021) 33
FIGURE 10 TRANSFECTION TECHNOLOGIES MARKET, BY END USER, 2016 VS. 2021 34
FIGURE 11 TRANSFECTION TECHNOLOGIES MARKET, BY APPLICATION,
2016 VS. 2021 (USD MILLION) 35
FIGURE 12 ASIA-PACIFIC IS PROJECTED TO WITNESS THE HIGHEST GROWTH IN THE TRANSFECTION TECHNOLOGIES MARKET DURING THE FORECAST PERIOD 36
FIGURE 13 NORTH AMERICA IS ESTIMATED TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2016 37
FIGURE 14 BIOMEDICAL RESEARCH SEGMENT TO DOMINATE THE TRANSFECTION TECHNOLOGIES MARKET IN 2016 38
FIGURE 15 ASIA-PACIFIC IS PROJECTED TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 39
FIGURE 16 REAGENTS SEGMENT IS PROJECTED TO ACCOUNT FOR THE LARGEST SHARE THROUGH 2021 40
FIGURE 17 ACADEMIC & RESEARCH INSTITUTES SEGMENT IS EXPECTED TO DOMINATE
THE MARKET THROUGH 2021 40
FIGURE 18 MARKET DYNAMICS 42
FIGURE 19 TRANSFECTION TECHNOLOGIES MARKET SIZE, BY PRODUCT,
2016–2021 (USD MILLION) 52
FIGURE 20 TRANSFECTION TECHNOLOGIES MARKET, BY METHOD,
2016 VS. 2021 (USD MILLION) 57
FIGURE 21 TRANSFECTION TECHNOLOGIES MARKET: BY APPLICATION 74
FIGURE 22 TRANSFECTION TECHNOLOGIES MARKET SIZE, BY END USER,
2016 VS. 2021 (USD MILLION) 84
FIGURE 23 TRANSFECTION TECHNOLOGIES MARKET: BY REGION, 2016-2021 89
FIGURE 24 NORTH AMERICA: TRANSFECTION TECHNOLOGIES MARKET SNAPSHOT 91
FIGURE 25 EUROPE : TRANSFECTION TECHNOLOGIES MARKET SNAPSHOT 108
FIGURE 26 ASIA-PACIFIC: TRANSFECTION TECHNOLOGIES MARKET SNAPSHOT 130
FIGURE 27 AGREEMENTS, COLLABORATIONS, AND PARTNERSHIPS, ARE THE MAJOR STRATEGIES ADOPTED BY THE KEY PLAYERS, 2013–2016 161
FIGURE 28 GLOBAL TRANSFECTION TECHNOLOGIES MARKET SHARE, BY KEY PLAYER, 2015 162
FIGURE 29 AGREEMENTS,COLLABORATIONS, AND PARTNERSHIPS: KEY STRATEGY ADOPTED BY PLAYERS (2013–2016) 165
FIGURE 30 AGREEMENTS, COLLABORATIONS AND PARTNERSHIPS,
BY COMPANY (2013–2016) 166
FIGURE 31 NEW PRODUCT LAUNCHES, BY COMPANY (2013–2016) 168
FIGURE 32 EXPANSIONS, BY COMPANY (2013–2016) 169
FIGURE 33 ACQUISITION, BY COMPANY (2013–2016) 170
FIGURE 34 OTHER STRATEGIES, BY COMPANY (2013–2016) 171
FIGURE 35 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT 172
FIGURE 36 PROMEGA CORPORATION: COMPANY SNAPSHOT 175
FIGURE 37 QIAGEN N.V.: COMPANY SNAPSHOT 177
FIGURE 38 ROCHE: COMPANY SNAPSHOT 180
FIGURE 39 BIO-RAD LABORATORIES: COMPANY SNAPSHOT 182
FIGURE 40 MAXCYTE INC.: COMPANY SNAPSHOT 184
FIGURE 41 LONZA GROUP: COMPANY SNAPSHOT 186
FIGURE 42 MERCK KGAA : COMPANY SNAPSHOT 189
FIGURE 43 SIGMA ALDRICH CORPORATION : COMPANY SNAPSHOT 190


【レポートのキーワード】

トランスフェクション試薬、トランスフェクション装置、方法、トランスフェクション試薬用途、生物医学、蛋白質製造、需要先

★調査レポート[トランスフェクション試薬&装置の世界市場予測(~2021):方法別、用途別(生物医学、蛋白質製造)、需要先別] ( Transfection Reagents and Equipment Market by Method (Biochemical (Calcium Phosphate, Lipofection, Dendrimers), Physical (Electroporation, Nucleofection), Viral)), Application (Biomedical, Protein Production), End User - Global Forecast to 2021 / MAM-BT-3562) 販売に関する免責事項
[トランスフェクション試薬&装置の世界市場予測(~2021):方法別、用途別(生物医学、蛋白質製造)、需要先別] ( Transfection Reagents and Equipment Market by Method (Biochemical (Calcium Phosphate, Lipofection, Dendrimers), Physical (Electroporation, Nucleofection), Viral)), Application (Biomedical, Protein Production), End User - Global Forecast to 2021 / MAM-BT-3562) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆